MIR99AHG/miR-204-5p/TXNIP/Nrf2/ARE Signaling Pathway Decreases Glioblastoma Temozolomide Sensitivity
Author:
Publisher
Springer Science and Business Media LLC
Subject
Toxicology,General Neuroscience
Link
https://link.springer.com/content/pdf/10.1007/s12640-022-00536-0.pdf
Reference34 articles.
1. Arora A, Somasundaram K (2019) Glioblastoma vs temozolomide: can the red queen race be won? Cancer Biol Ther 20(8):1083–1090. https://doi.org/10.1080/15384047.2019.1599662
2. Campos B, Olsen LR, Urup T, Poulsen HS (2016) A comprehensive profile of recurrent glioblastoma. Oncogene 35(45):5819–5825. https://doi.org/10.1038/onc.2016.85
3. Cao J, Han X, Qi X, Jin X, Li X (2018) miR-204-5p inhibits the occurrence and development of osteoarthritis by targeting Runx2. Int J Mol Med 42(5):2560–2568. https://doi.org/10.3892/ijmm.2018.3811
4. Cao W, Zhou G (2020) LncRNA SNHG12 contributes proliferation, invasion and epithelial-mesenchymal transition of pancreatic cancer cells by absorbing miRNA-320b. Biosci Rep. https://doi.org/10.1042/bsr20200805
5. Chavda V, Patel V, Yadav D, Shah J, Patel S, Jin JO (2020) Therapeutics and research related to glioblastoma: advancements and future targets. Curr Drug Metab 21(3):186–198. https://doi.org/10.2174/1389200221666200408083950
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. MicroRNA-204-5p Ameliorates Renal Injury via Regulating Keap1/Nrf2 Pathway in Diabetic Kidney Disease;Diabetes, Metabolic Syndrome and Obesity;2024-01
2. Identification of glioblastoma stem cell-associated lncRNAs using single-cell RNA sequencing datasets;Stem Cell Reports;2023-11
3. Identification of a novel MSI-related ceRNA network for predicting the prognosis and immunotherapy response of gastric cancer;Aging;2023-06-12
4. Recent advances in ferroptosis and therapeutic strategies for glioblastoma;Frontiers in Molecular Biosciences;2023-01-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3